The role of microparticles in inflammation and transfusion: A concise review

Transfusion and Apheresis Science

Volumn 53, Issue 2, 2015, Pages 159-167

  Cognasse, Fabrice ^a,b   Hamzeh Cognasse, Hind ^b   Laradi, Sandrine ^a,b   Chou, Ming Li ^c   Seghatchian, Jerard ^d   Burnouf, Thierry ^e   Boulanger, Chantal ^f   Garraud, Olivier ^b,g   Amabile, Nicolas ^f  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b UNIVERSITÉ DE LYON   (France)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d International Consultancy in Blood Components Quality Safety Improvement   (United Kingdom)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^g INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

Inflammation; MPs; Transfusion

Indexed keywords

CELL MEMBRANE; ERYTHROCYTE PRESERVATION; ERYTHROPOIESIS; HUMAN; INFLAMMATION; MEMBRANE MICROPARTICLE; PATHOPHYSIOLOGY; REVIEW; THROMBOCYTE PRESERVATION; THROMBOCYTOPOIESIS; TRANSFUSION; ANIMAL; BLOOD; BLOOD CELL; BLOOD COMPONENT THERAPY; CYTOSKELETON; ENDOTHELIUM CELL; LIPID BILAYER; METABOLISM; PATHOLOGY;

LIPID BILAYER; MEMBRANE PROTEIN;

ANIMALS; BLOOD CELLS; BLOOD COMPONENT TRANSFUSION; CELL-DERIVED MICROPARTICLES; CYTOSKELETON; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; LIPID BILAYERS; MEMBRANE PROTEINS;

EID: 84983155181     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2015.10.013     Document Type: Review

References (123)

1. Lacroix R., Dubois C., Leroyer A.S., Sabatier F., Dignat-George F. Revisited role of microparticles in arterial and venous thrombosis. J Thromb Haemost 2013, 11(Suppl. 1):24-35.
2. Jesel L., Abbas M., Toti F., Cohen A., Arentz T., Morel O. Microparticles in atrial fibrillation: a link between cell activation or apoptosis, tissue remodelling and thrombogenicity. Int J Cardiol 2013, 168:660-669.
3. Morel O., Jesel L., Freyssinet J.M., Toti F. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 2011, 31:15-26.
4. Mause S.F., Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010, 107:1047-1057.
5. Goubran H.A., Burnouf T., Stakiw J., Seghatchian J. Platelet microparticle: a sensitive physiological "fine tuning" balancing factor in health and disease. Transfus Apher Sci 2015, 52:12-18.
6. Dengler V., Downey G.P., Tuder R.M., Eltzschig H.K., Schmidt E.P. Neutrophil intercellular communication in acute lung injury. Emerging roles of microparticles and gap junctions. Am J Respir Cell Mol Biol 2013, 49:1-5.
7. Markiewicz M., Richard E., Marks N., Ludwicka-Bradley A. Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases. J Aging Res 2013, 2013:734509.
8. van der Pol E., Coumans F., Varga Z., Krumrey M., Nieuwland R. Innovation in detection of microparticles and exosomes. J Thromb Haemost 2013, 11(Suppl. 1):36-45.
9. Flaumenhaft R. Formation and fate of platelet microparticles. Blood Cells Mol Dis 2006, 36:182-187.
10. Wolfs J.L., Comfurius P., Rasmussen J.T., Keuren J.F., Lindhout T., Zwaal R.F., et al. Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction. Cell Mol Life Sci 2005, 62:1514-1525.
11. Enjeti A.K., Lincz L.F., Seldon M. Microparticles in health and disease. Semin Thromb Hemost 2008, 34:683-691.
12. Hankins H.M., Baldridge R.D., Xu P., Graham T.R. Role of flippases, scramblases and transfer proteins in phosphatidylserine subcellular distribution. Traffic 2015, 16:35-47.
13. van der Mark V.A., Elferink R.P., Paulusma C.C. P4 ATPases: flippases in health and disease. Int J Mol Sci 2013, 14:7897-7922.
14. van Meer G. Dynamic transbilayer lipid asymmetry. Cold Spring Harb Perspect Biol 2011, 3.
15. Kodigepalli K.M., Bowers K., Sharp A., Nanjundan M. Roles and regulation of phospholipid scramblases. FEBS Lett 2015, 589:3-14.
16. Van den Eijnde S.M., Boshart L., Reutelingsperger C.P., De Zeeuw C.I., Vermeij-Keers C. Phosphatidylserine plasma membrane asymmetry in vivo: a pancellular phenomenon which alters during apoptosis. Cell Death Differ 1997, 4:311-316.
17. Fabisiak J.P., Tyurina Y.Y., Tyurin V.A., Kagan V.E. Quantification of selective phosphatidylserine oxidation during apoptosis. Methods Mol Biol 2014, 1105:603-611.
18. Gillies L.A., Kuwana T. Apoptosis regulation at the mitochondrial outer membrane. J Cell Biochem 2014, 115:632-640.
19. Czabotar P.E., Lessene G., Strasser A., Adams J.M. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 2014, 15:49-63.
20. Horstman L.L., Ahn Y.S. Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 1999, 30:111-142.
21. Bode A.P., Orton S.M., Frye M.J., Udis B.J. Vesiculation of platelets during in vitro aging. Blood 1991, 77:887-895.
22. Burnouf T., Chou M.L., Goubran H.A., Cognasse F., Garaud O., Seghatchian J. An overview of the role of microparticles/microvesicles in blood components: are they clinically beneficial or harmful ?. Transfus Apher Sci 2015, 53(2):137-145.
23. Solum N.O. Procoagulant expression in platelets and defects leading to clinical disorders. Arterioscler Thromb Vasc Biol 1999, 19:2841-2846.
24. Chironi G., Simon A., Hugel B., Del Pino M., Gariepy J., Freyssinet J.M., et al. Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects. Arterioscler Thromb Vasc Biol 2006, 26:2775-2780.
25. Tan K.T., Lip G.Y. The potential role of platelet microparticles in atherosclerosis. Thromb Haemost 2005, 94:488-492.
26. Brogan P.A., Shah V., Brachet C., Harnden A., Mant D., Klein N., et al. Endothelial and platelet microparticles in vasculitis of the young. Arthritis Rheum 2004, 50:927-936.
27. Kambas K., Chrysanthopoulou A., Vassilopoulos D., Apostolidou E., Skendros P., Girod A., et al. Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease. Ann Rheum Dis 2014, 73:1854-1863.
28. Thaler J., Ay C., Mackman N., Bertina R.M., Kaider A., Marosi C., et al. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J Thromb Haemost 2012, 10:1363-1370.
29. Chirinos J.A., Heresi G.A., Velasquez H., Jy W., Jimenez J.J., Ahn E., et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 2005, 45:1467-1471.
30. Mallat Z., Benamer H., Hugel B., Benessiano J., Steg P.G., Freyssinet J.M., et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000, 101:841-843.
31. Montoro-Garcia S., Shantsila E., Tapp L.D., Lopez-Cuenca A., Romero A.I., Hernandez-Romero D., et al. Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes. Atherosclerosis 2013, 227:313-322.
32. Sinning J.M., Losch J., Walenta K., Bohm M., Nickenig G., Werner N. Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J 2011, 32:2034-2041.
33. Nozaki T., Sugiyama S., Koga H., Sugamura K., Ohba K., Matsuzawa Y., et al. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cardiol 2009, 54:601-608.
34. Tramontano A.F., Lyubarova R., Tsiakos J., Palaia T., Deleon J.R., Ragolia L. Circulating endothelial microparticles in diabetes mellitus. Mediators Inflamm 2010, 2010:250476.
35. Nomura S. Dynamic role of microparticles in type 2 diabetes mellitus. Curr Diabetes Rev 2009, 5:245-251.
36. Stepanian A., Bourguignat L., Hennou S., Coupaye M., Hajage D., Salomon L., et al. Microparticle increase in severe obesity: not related to metabolic syndrome and unchanged after massive weight loss. Obesity (Silver Spring) 2013, 21:2236-2243.
37. Agouni A., Lagrue-Lak-Hal A.H., Ducluzeau P.H., Mostefai H.A., Draunet-Busson C., Leftheriotis G., et al. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol 2008, 173:1210-1219.
38. Amabile N., Cheng S., Renard J.M., Larson M.G., Ghorbani A., McCabe E., et al. Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study. Eur Heart J 2014, 35:2972-2979.
39. Zahra S., Anderson J.A., Stirling D., Ludlam C.A. Microparticles, malignancy and thrombosis. Br J Haematol 2011, 152:688-700.
40. Zwicker J.I., Liebman H.A., Neuberg D., Lacroix R., Bauer K.A., Furie B.C., et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res 2009, 15:6830-6840.
41. Marcos-Ramiro B., Oliva Nacarino P., Serrano-Pertierra E., Blanco-Gelaz M.A., Weksler B.B., Romero I.A., et al. Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function. BMC Neurosci 2014, 15:110.
42. Saenz-Cuesta M., Irizar H., Castillo-Trivino T., Munoz-Culla M., Osorio-Querejeta I., Prada A., et al. Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis. Biomark Med 2014, 8:653-661.
43. Boilard E., Nigrovic P.A., Larabee K., Watts G.F., Coblyn J.S., Weinblatt M.E., et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010, 327:580-583.
44. Knijff-Dutmer E.A., Koerts J., Nieuwland R., Kalsbeek-Batenburg E.M., van de Laar M.A. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum 2002, 46:1498-1503.
45. Ostergaard O., Nielsen C.T., Iversen L.V., Tanassi J.T., Knudsen S., Jacobsen S., et al. Unique protein signature of circulating microparticles in systemic lupus erythematosus. Arthritis Rheum 2013, 65:2680-2690.
46. Nielsen C.T., Ostergaard O., Stener L., Iversen L.V., Truedsson L., Gullstrand B., et al. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation. Arthritis Rheum 2012, 64:1227-1236.
47. Breen K.A., Sanchez K., Kirkman N., Seed P.T., Parmar K., Moore G.W., et al. Endothelial and platelet microparticles in patients with antiphospholipid antibodies. Thromb Res 2014, 135(2):368-374.
48. Chaturvedi S., Cockrell E., Espinola R., Hsi L., Fulton S., Khan M., et al. Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations. Thromb Res 2015, 135:102-108.
49. Kozuma Y., Sawahata Y., Takei Y., Chiba S., Ninomiya H. Procoagulant properties of microparticles released from red blood cells in paroxysmal nocturnal haemoglobinuria. Br J Haematol 2011, 152:631-639.
50. Simak J., Holada K., Risitano A.M., Zivny J.H., Young N.S., Vostal J.G. Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria. Br J Haematol 2004, 125:804-813.
51. Mullier F., Minet V., Bailly N., Devalet B., Douxfils J., Chatelain C., et al. Platelet microparticle generation assay: a valuable test for immune heparin-induced thrombocytopenia diagnosis. Thromb Res 2014, 133:1068-1073.
52. Kasthuri R.S., Glover S.L., Jonas W., McEachron T., Pawlinski R., Arepally G.M., et al. PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcgammaRI. Blood 2012, 119:5285-5293.
53. Sewify E.M., Sayed D., Abdel Aal R.F., Ahmad H.M., Abdou M.A. Increased circulating red cell microparticles (RMP) and platelet microparticles (PMP) in immune thrombocytopenic purpura. Thromb Res 2013, 131:e59-63.
54. Jimenez J.J., Jy W., Mauro L.M., Horstman L.L., Soderland C., Ahn Y.S. Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation. Br J Haematol 2003, 123:896-902.
55. Tantawy A.A., Adly A.A., Ismail E.A., Habeeb N.M., Farouk A. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: relation to cardiovascular complications. Platelets 2013, 24:605-614.
56. van Beers E.J., Schaap M.C., Berckmans R.J., Nieuwland R., Sturk A., van Doormaal F.F., et al. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 2009, 94:1513-1519.
57. El-Assaad F., Wheway J., Hunt N.H., Grau G.E., Combes V. Production, fate and pathogenicity of plasma microparticles in murine cerebral malaria. PLoS Pathog 2014, 10:e1003839.
58. Reid V.L., Webster N.R. Role of microparticles in sepsis. Br J Anaesth 2012, 109:503-513.
59. Nieuwland R., Berckmans R.J., McGregor S., Boing A.N., Romijn F.P., Westendorp R.G., et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000, 95:930-935.
60. Frleta D., Ochoa C.E., Kramer H.B., Khan S.A., Stacey A.R., Borrow P., et al. HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44. J Clin Invest 2012, 122:4685-4697.
61. Baker J.V., Huppler Hullsiek K., Bradford R.L., Prosser R., Tracy R.P., Key N.S. Circulating levels of tissue factor microparticle procoagulant activity are reduced with antiretroviral therapy and are associated with persistent inflammation and coagulation activation among HIV-positive patients. J Acquir Immune Defic Syndr 2013, 63:367-371.
62. Stadnicki A. Thrombin generation and microparticles in inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 2013, 56:343.
63. Leonetti D., Reimund J.M., Tesse A., Viennot S., Martinez M.C., Bretagne A.L., et al. Circulating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions. PLoS ONE 2013, 8:e73088.
64. Choi H.Y., Moon S.J., Ratliff B.B., Ahn S.H., Jung A., Lee M., et al. Microparticles from kidney-derived mesenchymal stem cells act as carriers of proangiogenic signals and contribute to recovery from acute kidney injury. PLoS ONE 2014, 9:e87853.
65. Gao C., Xie R., Yu C., Wang Q., Shi F., Yao C., et al. Procoagulant activity of erythrocytes and platelets through phosphatidylserine exposure and microparticles release in patients with nephrotic syndrome. Thromb Haemost 2012, 107:681-689.
66. Amabile N., Guerin A.P., Leroyer A., Mallat Z., Nguyen C., Boddaert J., et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005, 16:3381-3388.
67. Wiedmer T., Shattil S.J., Cunningham M., Sims P.J. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry 1990, 29:623-632.
68. Iwamoto S., Kawasaki T., Kambayashi J., Ariyoshi H., Shinoki N., Sakon M., et al. The release mechanism of platelet-activating factor during shear-stress induced platelet aggregation. Biochem Biophys Res Commun 1997, 239:101-105.
69. Diamant M., Tushuizen M.E., Sturk A., Nieuwland R. Cellular microparticles: new players in the field of vascular disease?. Eur J Clin Invest 2004, 34:392-401.
70. Prudent M., Crettaz D., Delobel J., Tissot J.D., Lion N. Differences between stimulated and natural erythrocytes-derived microvesicles. Transfus Apher Sci 2015, 53(2):153-158.
71. Liu C., Liu X., Janes J., Stapley R., Patel R.P., Gladwin M.T., et al. Mechanism of faster NO scavenging by older stored red blood cells. Redox Biol 2014, 2:211-219.
72. Satta N., Toti F., Feugeas O., Bohbot A., Dachary-Prigent J., Eschwege V., et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 1994, 153:3245-3255.
73. Mesri M., Altieri D.C. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem 1999, 274:23111-23118.
74. Osmanovic N., Romijn F.P., Joop K., Sturk A., Nieuwland R. Soluble selectins in sepsis: microparticle-associated, but only to a minor degree. Thromb Haemost 2000, 84:731-732.
75. Shet A.S. Characterizing blood microparticles: technical aspects and challenges. Vasc Health Risk Manag 2008, 4:769-774.
76. Sabatier F., Roux V., Anfosso F., Camoin L., Sampol J., Dignat-George F. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood 2002, 99:3962-3970.
77. Schiro A., Wilkinson F.L., Weston R., Smyth J.V., Serracino-Inglott F., Alexander M.Y. Endothelial microparticles as conveyors of information in atherosclerotic disease. Atherosclerosis 2014, 234:295-302.
78. Helbing T., Olivier C., Bode C., Moser M., Diehl P. Role of microparticles in endothelial dysfunction and arterial hypertension. World J Cardiol 2014, 6:1135-1139.
79. Nurden A.T. Platelets, inflammation and tissue regeneration. Thromb Haemost 2011, 105(Suppl. 1):S13-33.
80. Cloutier N., Tan S., Boudreau L.H., Cramb C., Subbaiah R., Lahey L., et al. The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes. EMBO Mol Med 2013, 5:235-249.
81. Daniel L., Fakhouri F., Joly D., Mouthon L., Nusbaum P., Grunfeld J.P., et al. Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int 2006, 69:1416-1423.
82. Fourcade O., Simon M.F., Viode C., Rugani N., Leballe F., Ragab A., et al. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 1995, 80:919-927.
83. Barry O.P., FitzGerald G.A. Mechanisms of cellular activation by platelet microparticles. Thromb Haemost 1999, 82:794-800.
84. Barry O.P., Kazanietz M.G., Pratico D., FitzGerald G.A. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J Biol Chem 1999, 274:7545-7556.
85. Barry O.P., Pratico D., Lawson J.A., FitzGerald G.A. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997, 99:2118-2127.
86. Xie R.F., Hu P., Wang Z.C., Yang J., Yang Y.M., Gao L., et al. Platelet-derived microparticles induce polymorphonuclear leukocyte-mediated damage of human pulmonary microvascular endothelial cells. Transfusion 2015, 55(5):1051-1057.
87. Zibara K., Chignier E., Covacho C., Poston R., Canard G., Hardy P., et al. Modulation of expression of endothelial intercellular adhesion molecule-1, platelet-endothelial cell adhesion molecule-1, and vascular cell adhesion molecule-1 in aortic arch lesions of apolipoprotein E-deficient compared with wild-type mice. Arterioscler Thromb Vasc Biol 2000, 20:2288-2296.
88. Barry O.P., Pratico D., Savani R.C., FitzGerald G.A. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998, 102:136-144.
89. Nomura S., Imamura A., Okuno M., Kamiyama Y., Fujimura Y., Ikeda Y., et al. Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokines. Thromb Res 2000, 98:257-268.
90. Forlow S.B., McEver R.P., Nollert M.U. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 2000, 95:1317-1323.
91. Osumi K., Ozeki Y., Saito S., Nagamura Y., Ito H., Kimura Y., et al. Development and assessment of enzyme immunoassay for platelet-derived microparticles. Thromb Haemost 2001, 85:326-330.
92. George F.D. Microparticles in vascular diseases. Thromb Res 2008, 122(Suppl. 1):S55-9.
93. Gasser O., Schifferli J.A. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood 2004, 104:2543-2548.
94. Koppler B., Cohen C., Schlondorff D., Mack M. Differential mechanisms of microparticle transfer to B cells and monocytes: anti-inflammatory propertiesof microparticles. Eur J Immunol 2006, 36:648-660.
95. Hess J.R. Measures of stored red blood cell quality. Vox Sang 2014, 107:1-9.
96. Kent M.W., Kelher M.R., West F.B., Silliman C.C. The pro-inflammatory potential of microparticles in red blood cell units. Transfus Med 2014, 24:176-181.
97. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967, 13:269-288.
98. Burnouf T., Goubran H.A., Chou M.L., Devos D., Radosevic M. Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine. Blood Rev 2014, 28:155-166.
99. Blair P., Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 2009, 23:177-189.
100. Flaumenhaft R., Mairuhu A.T., Italiano J.E. Platelet- and megakaryocyte-derived microparticles. Semin Thromb Hemost 2010, 36:881-887.
101. Rubin O., Crettaz D., Canellini G., Tissot J.D., Lion N. Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools. Vox Sang 2008, 95:288-297.
102. Curvers J., van Pampus E.C., Feijge M.A., Rombout-Sestrienkova E., Giesen P.L., Heemskerk J.W. Decreased responsiveness and development of activation markers of PLTs stored in plasma. Transfusion 2004, 44:49-58.
103. Bode A.P., Knupp C.L. Effect of cold storage on platelet glycoprotein Ib and vesiculation. Transfusion 1994, 34:690-696.
104. Boing A.N., Hau C.M., Sturk A., Nieuwland R. Platelet microparticles contain active caspase 3. Platelets 2008, 19:96-103.
105. Matijevic N., Kostousov V., Wang Y.W., Wade C.E., Wang W., Letourneau P., et al. Multiple levels of degradation diminish hemostatic potential of thawed plasma. J Trauma 2011, 70:71-79. discussion 9-80.
106. Sinauridze E.I., Kireev D.A., Popenko N.Y., Pichugin A.V., Panteleev M.A., Krymskaya O.V., et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007, 97:425-434.
107. Lawrie A.S., Cardigan R.A., Williamson L.M., Machin S.J., Mackie I.J. The dynamics of clot formation in fresh-frozen plasma. Vox Sang 2008, 94:306-314.
108. Berckmans R.J., Nieuwland R., Boing A.N., Romijn F.P., Hack C.E., Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001, 85:639-646.
109. Phipps R.P., Kaufman J., Blumberg N. Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet 2001, 357:2023-2024.
110. Elzey B.D., Ratliff T.L., Sowa J.M., Crist S.A. Platelet CD40L at the interface of adaptive immunity. Thromb Res 2011, 127:180-183.
111. Blumberg N., Gettings K.F., Turner C., Heal J.M., Phipps R.P. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion 2006, 46:1813-1821.
112. Sahler J., Spinelli S., Phipps R., Blumberg N. CD40 ligand (CD154) involvement in platelet transfusion reactions. Transfus Clin Biol 2012, 19:98-103.
113. Sandgren P., Meinke S., Eckert E., Douagi I., Wikman A., Hoglund P. Random aggregates in newly produced platelet units are associated with platelet activation and release of the immunomodulatory factors sCD40L and RANTES. Transfusion 2014, 54(3):602-612.
114. Cognasse F., Boussoulade F., Chavarin P., Acquart S., Fabrigli P., Lamy B., et al. Release of potential immunomodulatory factors during platelet storage. Transfusion 2006, 46:1184-1189.
115. Hamzeh-Cognasse H., Damien P., Nguyen K.A., Arthaud C.A., Eyraud M.A., Chavarin P., et al. Immune-reactive soluble OX40 ligand, soluble CD40 ligand, and interleukin-27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions. Transfusion 2014, 54:613-625.
116. Aloui C., Prigent A., Sut C., Tariket S., Hamzeh-Cognasse H., Pozzetto B., et al. The signaling role of CD40 ligand in platelet biology and in platelet component transfusion. Int J Mol Sci 2014, 15:22342-22364.
117. Aloui C., Sut C., Prigent A., Fagan J., Cognasse F., Granados-Herbepin V., et al. Are polymorphisms of the immunoregulatory factor CD40LG implicated in acute transfusion reactions?. Sci Rep 2014, 4:7239.
118. Krailadsiri P., Seghatchian J. Are all leucodepleted platelet concentrates equivalent? Comparison of Cobe LRS Turbo, Haemonetics MCS+ LD, and filtered pooled buffy-coat-derived platelets. Vox Sang 2000, 78:171-175.
119. Thon J.N., Schubert P., Devine D.V. Platelet storage lesion: a new understanding from a proteomic perspective. Transfus Med Rev 2008, 22:268-279.
120. Schubert P., Devine D.V. Proteomics meets blood banking: identification of protein targets for the improvement of platelet quality. J Proteomics 2010, 73:436-444.
121. Krailadsiri P., Seghatchian J., Macgregor I., Drummond O., Perrin R., Spring F., et al. The effects of leukodepletion on the generation and removal of microvesicles and prion protein in blood components. Transfusion 2006, 46:407-417.
122. Poncelet P., Robert S., Bailly N., Garnache-Ottou F., Bouriche T., Devallet B., et al. Tips and tricks for flow cytometry-based analysis and counting of microparticles. Transfus Apher Sci 2015, 53(2):110-126.
123. Amiral J., Seghatchian J. The diagnostic usefulness of capture assays for measuring global/specific extracellular microparticles in plasma. Transfus Apher Sci 2015, 53(2):127-136.